Looking to the future, and hoping that current downward trends in malaria are sustained, we need to evaluate the newly introduced antimalarials (piperaquine and pyronaridine look promising12) as well as mefloquine to assess whether and when is the best time to give IPT.
intermittent preventive treatment
The Lancet, Volume 374, Issue 9700, 31 October 2009-6 November 2009, Pages 1478-1480
The Lancet, Volume 374, Issue 9700, 31 October 2009-6 November 2009, Pages 1533-1542
Intermittent preventive treatment (IPT) is a promising strategy for previous termmalarianext term control in infants. We undertook a pooled analysis of the safety and efficacy of IPT in infants (IPTi) with sulfadoxine-pyrimethamine in Africa.